477 Robot-Assisted Radical Cystectomy with HugoTM RAS robotic platform Dr. Simone Scuderi

This video is being presented at the Humans at the Cutting Edge of Robotic Surgery Symposium 2024, Jaipur, India. It was produced by Dr Simone Scuderi, Karolisnka Instiute, Stockholm, Sweden.
Abstract:
Robot-Assisted Radical Cystectomy with HugoTM RAS robotic platform
first case series by the European Association of Urology Robotic Urology Section (ERUS) Scientific
Working Group
Simone Scuderi1,2
, Juhana Rautiola2
, Chiara Sighinolfi3, Francesco Prata4
, Darko Bogdanovic2
, Francesco Tedesco4
, Ruben De
Groote5
, Francesco Barletta1,5
, Joan Palou Redorta6
, Andrea Gallioli6
, Giuseppe Basile1,6, Donato Cannoletta1,6
, Laura Merlo Pich7
,
Francesco Pellegrino1, Ugo Falagario2,8, Giuseppe Carrieri8
, Giorgio Gandaglia1
, Alberto Briganti1, Francesco Montorsi1
, Markus Aly2
,
Olof Akre2
, Bernardo Rocco3
, Rocco Papalia4, Alexander Mottrie5
, Alessandro Larcher1
, Alberto Breda6, Peter Wiklund2
1. Unit of Urology - Division of Oncology - Gianfranco Soldera Prostate Cancer Lab | IRCCS San Raffaele Scientific Institute - Vita-Salute San Raffaele
2. 3. 4. 5. 6. 7. 8. University, Milan, Italy
Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden
Department of Urology, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy
Fondazione Policlinico Universitario Campus Bio-Medico, Department of Urology, Rome, Italy
Department of Urology, O.L.V. Hospital, Aalst, Belgium
Department of Urology, Universitat Autonoma de Barcelona, Fundació Puigvert, Barcelona, Spain
Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.
Introduction & Objectives
This work is the first presenting patients’ perioperative and postoperative outcomes and describing the
surgical technique of robot-assisted radical cystectomy (RARC) with the Hugo™ RAS robotic platform.
Materials & Methods
We relied on a cohort of 26 consecutive patients receiving RARC with lymph node dissection at 5 referral
centers from the EAU Robotic Urology Section between 2023 and 2024. RARCs were performed
transperitoneally with a four-arm configuration. Complications were collected following the European
Association of Urology (EAU) recommendations. The main aims were the perioperative outcomes and the
90-day complication rates.
Results
One patient received a concomitant nephroureterectomy. Median age and BMI were 71y and 25kg/m². 18
patients were male, 6 received previous abdominal surgery, and the ASA score was 2-3 in 24. 17 patients
had cT2 stage and 2 were N1. A total of 9 and 7 patients received previous BCG and/or chemotherapy.
Median surgical time and blood loss were 285min and 250cc. Ileal conduit, neobladder, and
ureterocutaneostomy were performed in 8, 14, and 4 cases. Nerve-sparing was performed in 4 men and
organ-sparing in 6 women. A pelvic drain was placed in 17 patients. Median in-hospital stay was 7 days.
Intraoperative complications were recorded in 4 patients. 12 patients experienced any grade
complications within 90 days from surgery, of whom 3 were high-grade. The most common 90-day
complications were urinary tract infection (n=9), Ileus (n=6), and anemia requiring transfusion (n=5).
Conclusions
The Hugo™ RAS robotic platform has demonstrated safety and feasibility in performing RARCs
See more at: http://vfrsi.vattikutifoundation.com/